Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
107,681,582
-
Share change
-
-1,685,408
-
Total reported value
-
$871,701,309
-
Put/Call ratio
-
47%
-
Price per share
-
$8.10
-
Number of holders
-
155
-
Value change
-
-$13,441,907
-
Number of buys
-
77
-
Number of sells
-
51
Institutional Holders of ACHILLION PHARMACEUTICALS IN - COM (ACHN) as of Q3 2016
As of 30 Sep 2016,
ACHILLION PHARMACEUTICALS IN - COM (ACHN) was held by
155 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
107,681,582 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., JANUS CAPITAL MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, BlackRock Fund Advisors, STATE STREET CORP, BlackRock Institutional Trust Company, N.A., and FMR LLC.
This page lists
155
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.